Literature DB >> 23524570

Salvianolate inhibits reactive oxygen species production in H(2)O(2)-treated mouse cardiomyocytes in vitro via the TGFβ pathway.

Ai-hua Fei1, Qing Cao, Shu-yan Chen, Hai-rong Wang, Fei-long Wang, Shu-ming Pan, Zhao-fen Lin.   

Abstract

AIM: To investigate the effects of salvianolate, a water-soluble active compound from Salvia miltiorrhiza Bunge, on reactive oxygen species (ROS) production in mouse cardiomyocytes in vitro.
METHODS: Primary ventricular cardiomyocytes were prepared from neonatal mouse. The cell viability was determined using MTT assay. Culture medium for each treatment was collected for measuring the levels of NO, iNOS, total antioxidant capacity (TAOC) and transforming growth factor β1 (TGFβ1). TGFβ1 and Smad2/3 expression in the cells was detected with Western blotting.
RESULTS: H2O2 (1.25 mmol/L) did not significantly affect the cell viability, whereas the high concentration of salvianolate (5 g/L) alone dramatically suppressed the cell viability. Treatment of the cells with H2O2 (1.25 mmol/L) markedly increased ROS and iNOS production, and decreased the levels of NO, TAOC and TGFβ1 in the culture medium. Furthermore, the H2O2 treatment significantly increased TGFβ1 and Smad2/3 expression in the cells. Addition of salvianolate (0.05, 0.1, and 0.5 g/L) concentration-dependently reversed the H2O2-induced alterations in the culture medium; addition of salvianolate (0.05 g/L) reversed the H2O2-induced increases of TGFβ1 and Smad2/3 expression in the cells. Blockage of TGFβ1 with its antibody (1 mg/L) abolished the above mentioned effects of salvianolate.
CONCLUSION: Salvianolate inhibits ROS and iNOS production and increases TAOC and NO levels in H2O2-treated cardiomyocytes in vitro via downregulation of Smad2/3 and TGFβ1 expression. High concentration of salvianolate causes cytotoxicity in mouse cardiomyocytes.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23524570      PMCID: PMC4002796          DOI: 10.1038/aps.2012.209

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  17 in total

1.  Salvianolate inhibits proliferation and endothelin release in cultured rat mesangial cells.

Authors:  M Xu; Y P Wang; W B Luo; L J Xuan
Journal:  Acta Pharmacol Sin       Date:  2001-07       Impact factor: 6.150

2.  TGF beta1 induces prolonged mitochondrial ROS generation through decreased complex IV activity with senescent arrest in Mv1Lu cells.

Authors:  Young-Sil Yoon; Jae-Ho Lee; Sung-Chul Hwang; Kyeong Sook Choi; Gyesoon Yoon
Journal:  Oncogene       Date:  2005-03-10       Impact factor: 9.867

3.  The effect of xanthine oxidase inhibition upon ejection fraction in heart failure patients: La Plata Study.

Authors:  Horacio E Cingolani; Juan A Plastino; Eduardo M Escudero; Brian Mangal; Joanne Brown; Néstor G Pérez
Journal:  J Card Fail       Date:  2006-09       Impact factor: 5.712

Review 4.  Reactive oxygen species, mitochondria, and NAD(P)H oxidases in the development and progression of heart failure.

Authors:  Dan Sorescu; Kathy K Griendling
Journal:  Congest Heart Fail       Date:  2002 May-Jun

Review 5.  Oxidative stress and redox signalling in cardiac hypertrophy and heart failure.

Authors:  Mike Seddon; Yee H Looi; Ajay M Shah
Journal:  Heart       Date:  2006-05-02       Impact factor: 5.994

6.  Elevated systemic TGF-beta impairs aortic vasomotor function through activation of NADPH oxidase-driven superoxide production and leads to hypertension, myocardial remodeling, and increased plaque formation in apoE(-/-) mice.

Authors:  Anna Buday; Petra Orsy; Mária Godó; Miklós Mózes; Gábor Kökény; Zsombor Lacza; Akos Koller; Zoltán Ungvári; Marie-Luise Gross; Zoltán Benyó; Péter Hamar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-05-28       Impact factor: 4.733

7.  [Effect of salvianolate on migration of human vascular endothelial cells].

Authors:  Jie Xu; Wei-Hu Fan
Journal:  Zhong Xi Yi Jie He Xue Bao       Date:  2003-09

8.  Asbestos-derived reactive oxygen species activate TGF-beta1.

Authors:  Derek A Pociask; Patricia J Sime; Arnold R Brody
Journal:  Lab Invest       Date:  2004-08       Impact factor: 5.662

9.  Right-ventricular failure is associated with increased mitochondrial complex II activity and production of reactive oxygen species.

Authors:  Everaldo M Redout; Marijke J Wagner; Marian J Zuidwijk; Christa Boer; René J P Musters; Cornelis van Hardeveld; Walter J Paulus; Warner S Simonides
Journal:  Cardiovasc Res       Date:  2007-05-17       Impact factor: 10.787

Review 10.  Pharmacological actions and therapeutic applications of Salvia miltiorrhiza depside salt and its active components.

Authors:  Wen-yu Wu; Yi-ping Wang
Journal:  Acta Pharmacol Sin       Date:  2012-09-03       Impact factor: 6.150

View more
  11 in total

1.  Puerarin inhibits angiotensin II-induced cardiac hypertrophy via the redox-sensitive ERK1/2, p38 and NF-κB pathways.

Authors:  Gang Chen; Shi-qi Pan; Cong Shen; Shi-fen Pan; Xiu-min Zhang; Qi-yang He
Journal:  Acta Pharmacol Sin       Date:  2014-03-10       Impact factor: 6.150

2.  Salvianolate reduces murine myocardial ischemia and reperfusion injury via ERK1/2 signaling pathways in vivo.

Authors:  Jian-Yong Qi; Juan Yu; Dong-Hui Huang; Li-Heng Guo; Lei Wang; Xin Huang; Hai-Ding Huang; Miao Zhou; Min-Zhou Zhang; Jiashin Wu
Journal:  Chin J Integr Med       Date:  2016-10-27       Impact factor: 1.978

3.  Effects of salvianolate on myocardial perfusion after primary percutaneous catheter intervention in patients with ST-segment elevation myocardial infarction: a multicenter, randomized, double-blind, placebo-controlled study.

Authors:  Li Shen; Rende Xu; Jiasheng Yin; Hao Lu; Shuning Zhang; Zheyong Huang; Dong Huang; Hongying Liu; Juying Qian; Junbo Ge
Journal:  Ann Transl Med       Date:  2020-09

4.  A Prospective Randomized Multicenter Controlled Trial on Salvianolate for Treatment of Unstable Angina Pectoris in A Chinese Elderly Population.

Authors:  Hua Cui; Xiao-Ying Li; Xue-Wen Gao; Xiang Lu; Xiu-Ping Wu; Xiao-Fei Wang; Xiang-Qing Zheng; Kui Huang; Feng Liu; Zhi Luo; Hui-Shu Yuan; Gang Sun; Jian Kong; Xiao-Hong Du; Jin Zheng; Hong-Ying Liu; Wen-Ju Zhang
Journal:  Chin J Integr Med       Date:  2019-11-28       Impact factor: 1.978

5.  Effects of salvianolate on microcirculatory disturbance in patients with stable coronary heart disease: study protocol for a randomized controlled trial.

Authors:  Zhanlu Li; Yi Luan; Min Wang; Ya Li; Xiaohua Shen; Guosheng Fu; Wenbin Zhang
Journal:  Trials       Date:  2021-03-08       Impact factor: 2.279

6.  Cost-consequence analysis of salvianolate injection for the treatment of coronary heart disease.

Authors:  Pengxin Dong; Hao Hu; Xiaodong Guan; Carolina Oi Lam Ung; Luwen Shi; Sheng Han; Shuwen Yu
Journal:  Chin Med       Date:  2018-06-14       Impact factor: 5.455

7.  Puerarin Attenuates Cardiac Hypertrophy Partly Through Increasing Mir-15b/195 Expression and Suppressing Non-Canonical Transforming Growth Factor Beta (Tgfβ) Signal Pathway.

Authors:  Xiuzhou Zhang; Yuxiang Liu; Qingliang Han
Journal:  Med Sci Monit       Date:  2016-05-05

8.  Salvianolate Protects Hepatocytes from Oxidative Stress by Attenuating Mitochondrial Injury.

Authors:  Qiang Zhao; Yuan Peng; Kai Huang; Yang Lei; Hong-Liang Liu; Yan-Yan Tao; Cheng-Hai Liu
Journal:  Evid Based Complement Alternat Med       Date:  2016-06-02       Impact factor: 2.629

9.  Effects of salvianolate on bone metabolism in glucocorticoid-treated lupus-prone B6.MRL-Fas (lpr) /J mice.

Authors:  Yanzhi Liu; Yang Cui; Xiao Zhang; Xiang Gao; Yanjie Su; Bilian Xu; Tie Wu; Wenshuang Chen; Liao Cui
Journal:  Drug Des Devel Ther       Date:  2016-08-09       Impact factor: 4.162

10.  Cardiomyocyte depolarization triggers NOS-dependent NO transient after calcium release, reducing the subsequent calcium transient.

Authors:  Matias Mosqueira; Roland Konietzny; Carolin Andresen; Chao Wang; Rainer H A Fink
Journal:  Basic Res Cardiol       Date:  2021-03-17       Impact factor: 17.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.